Industry News
Cancer Patients On Lower Incomes Less Likely To Be Involved In Clinical Trials
Jun 05, 2012
Cancer patients with annual household incomes below $50,000 were less likely to participate in clinical trials than patients with annual incomes of $50,000 or higher, and were more likely to be concerned about how to pay for clinical trial participation... Read More
Duloxetine Helps Relieve Pain From Chemotherapy
Jun 05, 2012
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain. Chemotherapy-induced peripheral neuropathy is a common side effect of certain chemotherapy drugs... Read More
Not All Patients Will Pay For Genetic Testing
Jun 05, 2012
More than one-fifth of people who have received referrals to test for cancer-causing genes say they will only undergo testing if their insurance covers the cost - just as more insurers are instituting cost-sharing for medical services like genetic testing, according to new findings from Fox Chase Cancer Center in Philadelphia released at this year's 2012 Annual Meeting of the A... Read More
Disparities In Cancer Care Associated With A Patient's Socioeconomic Status
Jun 05, 2012
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival - cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision... Read More
Differences In Breast Cancer May Be Indicated By A Newly Discovered DNA Marker
Jun 05, 2012
Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is not experienced the same way with African American and Caucasian patients. This data was presented at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting... Read More
Lapatinib And Pazopanib Combo Not Found To Improve Outcomes For Patients With Inflammatory Breast Cancer
Jun 05, 2012
Inflammatory breast cancer is a very aggressive type of cancer associated with early metastasis and poor survival rates, and the prognosis is even worse for patients with tumors expressing the ErbB2 receptor. The ErbB2-inhibiting drug lapatinib can slow the spread of cancer cells in individuals with advanced breast cancer who have already tried other chemotherapy medications... Read More
During Radiation Treatment For Prostate Cancer The Antioxidant Beta-Carotene Found To Be Safe
Jun 05, 2012
Despite past safety concerns, the antioxidant supplement beta-carotene, is safe to use during radiation therapy treatments for prostate cancer and does not increase the risk of prostate cancer death or metastases, according to a study in the International Journal of Radiation Oncology-Biology-Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO)... Read More
Detailing Protein Pathways May Provide Clues In Leukemia Research
Jun 05, 2012
Scientists at Rice University and the University of Texas MD Anderson Cancer Center have successfully profiled protein pathways found to be distinctive to leukemia patients with particular variants of the disease. Their research involved the creation of a new computational approach to identifying complex networks in protein signaling... Read More
Novel Combination Activates Two Key Genes Involved In Lung Cancer
Jun 05, 2012
A team of researchers led by Dr. Goutham Narla at Case Western Reserve University School of Medicine in collaboration with scientists at Mount Sinai School of Medicine in New York, have discovered a previously unrecognized signaling network disrupted in lung cancer that can be turned back on by a novel combination of two previously approved FDA drugs... Read More
Notch Network Findings Further The Development Of Cancer, Heart Disease Therapeutics
Jun 05, 2012
By using laser microbeam technology called optical tweezers, UC Irvine and UCLA researchers have uncovered fundamental properties of a key molecular signaling system involved with development, cancer and cardiovascular disease... Read More
Previous Page Next Page